Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | TRUL | Subordinate Voting Shares | 115K | Jul 17, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | TRUL | Stock Option (Right to Buy) | Jul 17, 2024 | Subordinate Voting Shares | 19.5K | $26.88 | Direct | F2 | ||||||
holding | TRUL | Stock Option (Right to Buy) | Jul 17, 2024 | Subordinate Voting Shares | 49.7K | $21.48 | Direct | F3 | ||||||
holding | TRUL | Stock Option (Right to Buy) | Jul 17, 2024 | Subordinate Voting Shares | 128K | $3.99 | Direct | F4 | ||||||
holding | TRUL | Stock Option (Right to Buy) | Jul 17, 2024 | Subordinate Voting Shares | 67.9K | $10.00 | Direct | F5 |
Id | Content |
---|---|
F1 | The amount of securities beneficially owned in column 2 includes several grants of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. The reporting person: (i) was granted 17,458 RSUs on February 24, 2022, subject to 2-year vesting; the RSUs vested 50% on December 29, 2023 and will vest 50% on December 29, 2024; (ii) was granted 57,515 RSUs on July 25, 2023, subject to 2-year vesting; the RSUs will vest 50% on December 1, 2024 and 50% on December 1, 2025; and (iii) was granted 37,500 RSUs on March 8, 2024, subject to 2-year vesting; the RSUs will vest 50% on December 1, 2025 and 50% on December 1, 2026. |
F2 | The options were granted on September 29, 2021, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on each of December 1, 2021; December 1, 2022; and December 1, 2023. |
F3 | The options were granted on February 24, 2022, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on each of December 1, 2022; and December 1, 2023; one third of the options will vest and become exercisable on December 1, 2024. |
F4 | The options were granted on July 25, 2023, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on December 1, 2023; one third of the options will vest and become exercisable on December 1, 2024, and one third of the options will vest and become exercisable on December 1, 2025. |
F5 | The options were granted on March 8, 2024, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options will vest and become exercisable on December 1, 2024, one third of the options will vest and become exercisable on December 1, 2025, and one third of the options will vest and become exercisable on December 1, 2026. |